P

Inventor

NEEF GUENTER

DE43 patents
⚠️ This page may combine multiple inventors who share the name “NEEF GUENTER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING AG

39 patents
US5446035AAug 29, 1995

20-methyl-substituted vitamin D derivatives

SCHERING AG79 citations96
US5089488AFeb 18, 1992

β-(4-isopropenylphenyl)estra-4,9-dienes, their production, and pharmaceutical preparations containing same

SCHERING AG44 citations96
US4814327AMar 21, 1989

11 β-(4-isopropenylphenyl)estra-4,9-dienes, their production, and pharmaceutical preparations containing same

SCHERING AG49 citations96
US5411949AMay 2, 1995

23-oxa-derivatives in the vitamin D series, process for their production, pharmaceutical preparations containing these derivatives as well as their use pharmaceutical agents

SCHERING AG55 citations95
US4435403AMar 6, 1984

Pharmacologically active 3-substituted beta-carbolines

SCHERING AG46 citations95
US4780461AOct 25, 1988

13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same

SCHERING AG32 citations93
US6531459B1Mar 11, 2003

Vitamin D derivatives with phosphorus atoms in the side chains

SCHERING AG28 citations92
US6376480B1Apr 23, 2002

Vitamin D derivatives with substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents

SCHERING AG18 citations92
US6372731B1Apr 16, 2002

Vitamin D derivatives with C-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments

SCHERING AG21 citations92
US5843933ADec 1, 1998

11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents

SCHERING AG31 citations92
US5728689AMar 17, 1998

11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents

SCHERING AG18 citations92
US5663157ASep 2, 1997

22-en-25-oxa derivatives in the vitamin D series, process for their production, pharmaceutical preparations containing these derivatives as well as their use as pharmaceutical agents

SCHERING AG25 citations92
US5583125ADec 10, 1996

25-Carboxylic acid derivatives in the vitamin D series, process for their production, intermediate products for these processes, pharmaceutical preparations containing these derivatives as well as their use for the production of pharmaceutical agents

SCHERING AG37 citations92
US5446036AAug 29, 1995

13-alkyl-11beta-phenylgonanes

SCHERING AG32 citations92
US5273971ADec 28, 1993

13-alkyl-11β-phenylgonanes

SCHERING AG26 citations92
US4829060AMay 9, 1989

11 Beta-N,N-dimethylaminophenyl-estradienes, their manufacture and pharmaceutical preparations containing them

SCHERING AG32 citations92
US4536401AAug 20, 1985

11β-aryl estradienes, processes for their production and pharmaceutical preparations containing them

SCHERING AG29 citations92
US4870069ASep 26, 1989

11β-alkynyl-estrenes and -estradienes, their production and pharmaceutical preparations containing them

SCHERING AG27 citations91
US5089635AFeb 18, 1992

11 β-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them

SCHERING AG25 citations90
US5426102AJun 20, 1995

14β-H-, 14-and 15-En-11β-aryl-4-oestrenes

SCHERING AG20 citations83
US5132299AJul 21, 1992

11β-phenyl-4,9,15-estratrienes, their manufacture and pharmaceutical preparations containing same

SCHERING AG21 citations82
US4596808AJun 24, 1986

Pharmacologically active 3-substituted beta-carbolines useful as tranquilizers

SCHERING AG24 citations81
US6642218B2Nov 4, 2003

Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments

SCHERING AG7 citations73
US6613920B1Sep 2, 2003

Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents

SCHERING AG4 citations73
US5093507AMar 3, 1992

10β,11β-bridged steroids

SCHERING AG15 citations73
US7211680B2May 1, 2007

Vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments

SCHERING AG4 citations71
US6025507AFeb 15, 2000

Borneol derivatives, methods of manufacturing them, and their pharmaceutical use

SCHERING AG14 citations69
US5478956ADec 26, 1995

8-En-19 11 β-bridged steroids, their production and pharmaceutical preparations containing them

SCHERING AG16 citations68
US4066674AJan 3, 1978

Process for the preparation of 1,3-oxygenated 8α-estratrienes and novel intermediates obtained therefrom

SCHERING AG6 citations63
US5134136AJul 28, 1992

14α,17α-ethanoestratrienes

SCHERING AG4 citations62
US4333928AJun 8, 1982

16 α-Alkyl steroids, their preparation, and pharmaceutical preparations thereof

SCHERING AG3 citations62
US5792792AAug 11, 1998

Borenol derivatives, process for their production and their pharmaceutical use

SCHERING AG2 citations61
US4870067ASep 26, 1989

Oxytocins and antigestagens in combination for induction of birth

SCHERING AG2 citations58
US6596713B1Jul 22, 2003

Steroid esters and amides, process for their production and their pharmaceutical use

SCHERING AG2 citations57
US4843157AJun 27, 1989

13alpha-alkylgonan-delta 9(11)-5,10-epoxides

SCHERING AG5 citations54
US4603013AJul 29, 1986

Estrane derivatives

SCHERING AG1 citations52
US4298538ANov 3, 1981

16-Dimethylaminomethylene-3-methoxy-1,3,5-(10)-estratrien-17-one, a process for the preparation thereof and its use as a preparative intermediate

SCHERING AG1 citations52
US5965609AOct 12, 1999

Borneol esters, process for their production, and their pharmaceutical use

SCHERING AG1 citations51
US5529993AJun 25, 1996

14α, 17α-ethano-16α-hydroxy-estratrienes

SCHERING AG0 citations51

FERROSAN AS

2 patents

SCHERING AKTIENGELLSCHAFT

1 patent

SCHERING AKTIENSGESELLSCHAFT

1 patent